{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:21Z","timestamp":1792784901531,"version":"4.5.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["10046533"],"award-info":[{"award-number":["10046533"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Buntrock Fund for Bullous Pemphigoid Research"},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR075043"],"award-info":[{"award-number":["P30AR075043"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62495-2","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:40:15Z","timestamp":1754498415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes"],"prefix":"10.1038","volume":"16","author":[{"given":"Lei","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6245-6412","authenticated-orcid":false,"given":"Christian F.","family":"Guerrero-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4228-0003","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3226-3935","authenticated-orcid":false,"given":"Manuela","family":"Pigors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Emtenani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-4756","authenticated-orcid":false,"given":"Yingzi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian P.","family":"Mansini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu F.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadil","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-0599","authenticated-orcid":false,"given":"Bethany E.","family":"Perez White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-359X","authenticated-orcid":false,"given":"Stefan","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kunstman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-4259","authenticated-orcid":false,"given":"Mrinal K.","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-0812","authenticated-orcid":false,"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macias","family":"Virgilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Allen","family":"McAlexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McCrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5063-8788","authenticated-orcid":false,"given":"Christopher D.","family":"Nazaroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-8913","authenticated-orcid":false,"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2906-2454","authenticated-orcid":false,"given":"Kyle T.","family":"Amber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"62495_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","volume":"54","author":"KT Amber","year":"2018","unstructured":"Amber, K. T., Murrell, D. F., Schmidt, E., Joly, P. & Borradori, L. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin. Rev. Allergy Immunol. 54, 26\u201351 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"62495_CR2","doi-asserted-by":"crossref","unstructured":"Cole, C., Borradori, L. & Amber, K. T. Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid. Antibodies (Basel) 11, 44 (2022).","DOI":"10.3390\/antib11030044"},{"key":"62495_CR3","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","volume":"182","author":"S Hiroyasu","year":"2013","unstructured":"Hiroyasu, S. et al. Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway. Am. J. Pathol. 182, 828\u2013840 (2013).","journal-title":"Am. J. Pathol."},{"key":"62495_CR4","doi-asserted-by":"crossref","unstructured":"Bao, L. et al. FcRn inhibition reduces bullous pemphigoid anti-basement membrane zone IgG deposition and blistering in 3D human skin equivalents. J. Invest. Dermatol. 144, 2809\u20132812.e2 (2024).","DOI":"10.1016\/j.jid.2024.05.013"},{"key":"62495_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.912876","volume":"13","author":"C Cole","year":"2022","unstructured":"Cole, C., Vinay, K., Borradori, L. & Amber, K. T. Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms. Front Immunol. 13, 912876 (2022).","journal-title":"Front Immunol."},{"key":"62495_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.973702","volume":"13","author":"C Papara","year":"2022","unstructured":"Papara, C. et al. The relevance of complement in pemphigoid diseases: A critical appraisal. Front Immunol. 13, 973702 (2022).","journal-title":"Front Immunol."},{"key":"62495_CR7","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ajpath.2014.05.007","volume":"184","author":"FS Schulze","year":"2014","unstructured":"Schulze, F. S. et al. Fc\u03b3 receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. Am. J. Pathol. 184, 2185\u20132196 (2014).","journal-title":"Am. J. Pathol."},{"key":"62495_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fmed.2018.00201","volume":"5","author":"KT Amber","year":"2018","unstructured":"Amber, K. T., Valdebran, M., Kridin, K. & Grando, S. A. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease. Front Med (Lausanne) 5, 201 (2018).","journal-title":"Front Med (Lausanne)"},{"key":"62495_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.23736\/S0031-0808.20.03997-X","volume":"63","author":"VA Jones","year":"2021","unstructured":"Jones, V. A., Patel, P. M. & Amber, K. T. Eosinophils in bullous pemphigoid. Panminerva Med 63, 368\u2013378 (2021).","journal-title":"Panminerva Med"},{"key":"62495_CR10","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3389\/fimmu.2018.02687","volume":"9","author":"RM Chiorean","year":"2018","unstructured":"Chiorean, R. M. et al. Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients. Front Immunol. 9, 2687 (2018).","journal-title":"Front Immunol."},{"key":"62495_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fimmu.2018.00488","volume":"9","author":"CM Karsten","year":"2018","unstructured":"Karsten, C. M. et al. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2. Front Immunol. 9, 488 (2018).","journal-title":"Front Immunol."},{"key":"62495_CR12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/bjd.15924","volume":"177","author":"PC Freire","year":"2017","unstructured":"Freire, P. C., Mu\u00f1oz, C. H. & Stingl, G. IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants. Br. J. Dermatol 177, 1644\u20131653 (2017).","journal-title":"Br. J. Dermatol"},{"key":"62495_CR13","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.3389\/fimmu.2019.02331","volume":"10","author":"KN Messingham","year":"2019","unstructured":"Messingham, K. N., Crowe, T. P. & Fairley, J. A. The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid. Front Immunol. 10, 2331 (2019).","journal-title":"Front Immunol."},{"key":"62495_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","volume":"153","author":"N van Beek","year":"2017","unstructured":"van Beek, N. et al. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity. JAMA Dermatol 153, 30\u201338 (2017).","journal-title":"JAMA Dermatol"},{"key":"62495_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2249.2001.01503.x","volume":"124","author":"E Schmidt","year":"2001","unstructured":"Schmidt, E., Reimer, S., Kruse, N., Br\u00f6cker, E. B. & Zillikens, D. The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin. Exp. Immunol. 124, 157\u2013162 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"62495_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1523-1747.2000.00141.x","volume":"115","author":"E Schmidt","year":"2000","unstructured":"Schmidt, E. et al. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J. Invest Dermatol 115, 842\u2013848 (2000).","journal-title":"J. Invest Dermatol"},{"key":"62495_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.1001753","volume":"187","author":"KN Messingham","year":"2011","unstructured":"Messingham, K. N., Srikantha, R., DeGueme, A. M. & Fairley, J. A. FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid. J. Immunol. 187, 553\u2013560 (2011).","journal-title":"J. Immunol."},{"key":"62495_CR18","doi-asserted-by":"crossref","unstructured":"Ruan, Y. et al. Single-Cell Profiling Unveils the Inflammatory Heterogeneity within Cutaneous Lesions of Bullous Pemphigoid. J. Invest. Dermatol. 144, 2176\u20132186.e6 (2024).","DOI":"10.1016\/j.jid.2024.02.029"},{"key":"62495_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110219","volume":"263","author":"Z Hu","year":"2024","unstructured":"Hu, Z. et al. Single-cell sequencing reveals distinct immune cell features in cutaneous lesions of pemphigus vulgaris and bullous pemphigoid. Clin. Immunol. 263, 110219 (2024).","journal-title":"Clin. Immunol."},{"key":"62495_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.775412","volume":"12","author":"L Bao","year":"2021","unstructured":"Bao, L. et al. Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes. Front Immunol. 12, 775412 (2021).","journal-title":"Front Immunol."},{"key":"62495_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/exd.14501","volume":"31","author":"L Bao","year":"2022","unstructured":"Bao, L., Perez White, B. E., Li, J., Patel, P. M. & Amber, K. T. Gene expression profiling of laminin \u03b13-blocked keratinocytes reveals an immune-independent mechanism of blistering. Exp. Dermatol 31, 615\u2013621 (2022).","journal-title":"Exp. Dermatol"},{"key":"62495_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fonc.2020.00352","volume":"10","author":"VA Jones","year":"2020","unstructured":"Jones, V. A., Patel, P. M., Gibson, F. T., Cordova, A. & Amber, K. T. The Role of Collagen XVII in Cancer: Squamous Cell Carcinoma and Beyond. Front Oncol. 10, 352 (2020).","journal-title":"Front Oncol."},{"key":"62495_CR23","doi-asserted-by":"crossref","unstructured":"Tuusa, J., Kokkonen, N. & Tasanen, K. BP180\/Collagen XVII: A Molecular View. Int. J. Mol. Sci. 22, 12233 (2021).","DOI":"10.3390\/ijms222212233"},{"key":"62495_CR24","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1073\/pnas.1721805115","volume":"115","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. BP180 dysfunction triggers spontaneous skin inflammation in mice. Proc. Natl Acad. Sci. USA 115, 6434\u20136439 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"62495_CR25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/jid.2014.443","volume":"135","author":"T Hurskainen","year":"2015","unstructured":"Hurskainen, T. et al. Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice. J. Invest Dermatol 135, 1303\u20131310 (2015).","journal-title":"J. Invest Dermatol"},{"key":"62495_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/cup.12521","volume":"42","author":"A Saraiya","year":"2015","unstructured":"Saraiya, A. et al. Dermal eosinophilic infiltrate in junctional epidermolysis bullosa. J. Cutan. Pathol. 42, 559\u2013563 (2015).","journal-title":"J. Cutan. Pathol."},{"key":"62495_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10038-005-0282-4","volume":"50","author":"M Nomura","year":"2005","unstructured":"Nomura, M. et al. Eosinophil infiltration in three patients with generalized atrophic benign epidermolysis bullosa from a Japanese family: molecular genetic and immunohistochemical studies. J. Hum. Genet 50, 483\u2013489 (2005).","journal-title":"J. Hum. Genet"},{"key":"62495_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/archderm.1990.01670330071009","volume":"126","author":"RR Roth","year":"1990","unstructured":"Roth, R. R., Smith, K. J. & James, W. D. Eosinophilic infiltrates in epidermolysis bullosa. Arch. Dermatol 126, 1191\u20131194 (1990).","journal-title":"Arch. Dermatol"},{"key":"62495_CR29","doi-asserted-by":"publisher","first-page":"23386","DOI":"10.1074\/jbc.M109.034090","volume":"284","author":"CW Franzke","year":"2009","unstructured":"Franzke, C. W., Bruckner-Tuderman, L. & Blobel, C. P. Shedding of collagen XVII\/BP180 in skin depends on both ADAM10 and ADAM9. J. Biol. Chem. 284, 23386\u201323396 (2009).","journal-title":"J. Biol. Chem."},{"key":"62495_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ymthe.2017.09.022","volume":"26","author":"C Galiger","year":"2018","unstructured":"Galiger, C. et al. Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma Progression. Mol. Ther. 26, 17\u201330 (2018).","journal-title":"Mol. Ther."},{"key":"62495_CR31","doi-asserted-by":"publisher","first-page":"adv00054","DOI":"10.2340\/00015555-3399","volume":"100","author":"W Nishie","year":"2020","unstructured":"Nishie, W. Collagen XVII Processing and Blistering Skin Diseases. Acta Derm. Venereol. 100, adv00054 (2020).","journal-title":"Acta Derm. Venereol."},{"key":"62495_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.humpath.2014.11.020","volume":"46","author":"JM Moilanen","year":"2015","unstructured":"Moilanen, J. M. et al. Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer. Hum. Pathol. 46, 434\u2013442 (2015).","journal-title":"Hum. Pathol."},{"key":"62495_CR33","doi-asserted-by":"publisher","first-page":"24521","DOI":"10.1074\/jbc.M308835200","volume":"279","author":"CW Franzke","year":"2004","unstructured":"Franzke, C. W., Tasanen, K., Borradori, L., Huotari, V. & Bruckner-Tuderman, L. Shedding of collagen XVII\/BP180: structural motifs influence cleavage from cell surface. J. Biol. Chem. 279, 24521\u201324529 (2004).","journal-title":"J. Biol. Chem."},{"key":"62495_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0002-9440(10)64772-4","volume":"156","author":"H Schumann","year":"2000","unstructured":"Schumann, H. et al. The shed ectodomain of collagen XVII\/BP180 is targeted by autoantibodies in different blistering skin diseases. Am. J. Pathol. 156, 685\u2013695 (2000).","journal-title":"Am. J. Pathol."},{"key":"62495_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00403-019-01954-5","volume":"311","author":"M Valdebran","year":"2019","unstructured":"Valdebran, M. et al. Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses. Arch. Dermatol Res 311, 705\u2013710 (2019).","journal-title":"Arch. Dermatol Res"},{"key":"62495_CR36","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/ng.665","volume":"42","author":"D Depianto","year":"2010","unstructured":"Depianto, D., Kerns, M. L., Dlugosz, A. A. & Coulombe, P. A. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat. Genet 42, 910\u2013914 (2010).","journal-title":"Nat. Genet"},{"key":"62495_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1346-8138.1993.tb01295.x","volume":"20","author":"J Hunyadi","year":"1993","unstructured":"Hunyadi, J., Simon, M. Jr, Kenderessy, A. S. & Dobozy, A. Expression of monocyte\/macrophage markers (CD13, CD14, CD68) on human keratinocytes in healthy and diseased skin. J. Dermatol 20, 341\u2013345 (1993).","journal-title":"J. Dermatol"},{"key":"62495_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35319-w","volume":"13","author":"A Sch\u00e4bitz","year":"2022","unstructured":"Sch\u00e4bitz, A. et al. Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases. Nat. Commun. 13, 7729 (2022).","journal-title":"Nat. Commun."},{"key":"62495_CR39","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00403-021-02249-4","volume":"314","author":"L Bao","year":"2022","unstructured":"Bao, L., Li, J., Perez White, B. E., Patel, P. M. & Amber, K. T. Inhibition of dipeptidyl-peptidase 4 induces upregulation of the late cornified envelope cluster in keratinocytes. Arch. Dermatol Res 314, 909\u2013915 (2022).","journal-title":"Arch. Dermatol Res"},{"key":"62495_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50283-3","volume":"15","author":"T Liu","year":"2024","unstructured":"Liu, T. et al. Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease. Nat. Commun. 15, 5949 (2024).","journal-title":"Nat. Commun."},{"key":"62495_CR41","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/infdis\/jiab194","volume":"223","author":"H Miyachi","year":"2021","unstructured":"Miyachi, H. et al. Keratinocyte IL-36 Receptor\/MyD88 Signaling Mediates Malassezia-Induced IL-17-Dependent Skin Inflammation. J. Infect. Dis. 223, 1753\u20131765 (2021).","journal-title":"J. Infect. Dis."},{"key":"62495_CR42","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/jid.2008.261","volume":"129","author":"Y Lee","year":"2009","unstructured":"Lee, Y. et al. Myeloid differentiation factor 88 regulates basal and UV-induced expressions of IL-6 and MMP-1 in human epidermal keratinocytes. J. Invest Dermatol 129, 460\u2013467 (2009).","journal-title":"J. Invest Dermatol"},{"key":"62495_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/intimm\/dxg068","volume":"15","author":"A Pivarcsi","year":"2003","unstructured":"Pivarcsi, A. et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 15, 721\u2013730 (2003).","journal-title":"Int Immunol."},{"key":"62495_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fimmu.2018.00080","volume":"9","author":"WR Swindell","year":"2018","unstructured":"Swindell, W. R. et al. RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene Signature. Front Immunol. 9, 80 (2018).","journal-title":"Front Immunol."},{"key":"62495_CR45","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/exd.14791","volume":"32","author":"R Maglie","year":"2023","unstructured":"Maglie, R. et al. Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid. Exp. Dermatol 32, 915\u2013921 (2023).","journal-title":"Exp. Dermatol"},{"key":"62495_CR46","doi-asserted-by":"publisher","first-page":"R403","DOI":"10.1152\/ajpregu.00395.2009","volume":"298","author":"Y Yamawaki","year":"2010","unstructured":"Yamawaki, Y., Kimura, H., Hosoi, T. & Ozawa, K. MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R403\u2013R410 (2010).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"62495_CR47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.chom.2017.10.008","volume":"22","author":"S Nakagawa","year":"2017","unstructured":"Nakagawa, S. et al. Staphylococcus aureus Virulent PSM\u03b1 Peptides Induce Keratinocyte Alarmin Release to Orchestrate IL-17-Dependent Skin Inflammation. Cell Host Microbe 22, 667\u2013677.e665 (2017).","journal-title":"Cell Host Microbe"},{"key":"62495_CR48","doi-asserted-by":"publisher","first-page":"8551","DOI":"10.1073\/pnas.96.15.8551","volume":"96","author":"V Vasioukhin","year":"1999","unstructured":"Vasioukhin, V., Degenstein, L., Wise, B. & Fuchs, E. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc. Natl Acad. Sci. USA 96, 8551\u20138556 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"62495_CR49","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.immuni.2008.05.016","volume":"29","author":"B Hou","year":"2008","unstructured":"Hou, B., Reizis, B. & DeFranco, A. L. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29, 272\u2013282 (2008).","journal-title":"Immunity"},{"key":"62495_CR50","doi-asserted-by":"crossref","unstructured":"Pigors, M. et al. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A\/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade. J. Pathol. 262, 161\u2013174 (2024).","DOI":"10.1002\/path.6220"},{"key":"62495_CR51","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1111\/jdv.19593","volume":"38","author":"N Kotnik","year":"2024","unstructured":"Kotnik, N. et al. Infiltration analysis of eosinophils and basophils and co-expression of CD69, CD63, IL-31 and IgE in patients with bullous and non-bullous pemphigoid. J. Eur. Acad. Dermatol Venereol. 38, e278\u2013e281 (2024).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"62495_CR52","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jid.2023.01.029","volume":"143","author":"A Lamberts","year":"2023","unstructured":"Lamberts, A. et al. Gene Expression Profiling Suggests that Complement Activation Is Important for Blister Formation in Bullous Pemphigoid. J. Invest Dermatol 143, 1591\u20131594.e1592 (2023).","journal-title":"J. Invest Dermatol"},{"key":"62495_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly, P. et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N. Engl. J. Med 346, 321\u2013327 (2002).","journal-title":"N. Engl. J. Med"},{"key":"62495_CR54","doi-asserted-by":"crossref","unstructured":"Jiang, Y. et al. Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin. JCI Insight 5, e142067 (2020).","DOI":"10.1172\/jci.insight.142067"},{"key":"62495_CR55","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jid.2017.08.030","volume":"138","author":"A Kasprick","year":"2018","unstructured":"Kasprick, A. et al. The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies. J. Invest Dermatol 138, 458\u2013461 (2018).","journal-title":"J. Invest Dermatol"},{"key":"62495_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1194088","volume":"14","author":"T Yan","year":"2023","unstructured":"Yan, T. et al. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. Front Immunol. 14, 1194088 (2023).","journal-title":"Front Immunol."},{"key":"62495_CR57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/bjd\/ljad136","volume":"189","author":"P Moghadam","year":"2023","unstructured":"Moghadam, P. et al. Efficacy and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients. Br. J. Dermatol 189, 244\u2013246 (2023).","journal-title":"Br. J. Dermatol"},{"key":"62495_CR58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jaad.2023.03.036","volume":"89","author":"C Learned","year":"2023","unstructured":"Learned, C. et al. Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review. J. Am. Acad. Dermatol 89, 378\u2013382 (2023).","journal-title":"J. Am. Acad. Dermatol"},{"key":"62495_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2020.01.089","volume":"83","author":"R Abdat","year":"2020","unstructured":"Abdat, R. et al. Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series. J. Am. Acad. Dermatol 83, 46\u201352 (2020).","journal-title":"J. Am. Acad. Dermatol"},{"key":"62495_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1135002","volume":"14","author":"H Koga","year":"2023","unstructured":"Koga, H. et al. Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid. Front Immunol. 14, 1135002 (2023).","journal-title":"Front Immunol."},{"key":"62495_CR61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri3824","volume":"15","author":"MH Kaplan","year":"2015","unstructured":"Kaplan, M. H., Hufford, M. M. & Olson, M. R. The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15, 295\u2013307 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"62495_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00281-016-0606-9","volume":"39","author":"P Licona-Lim\u00f3n","year":"2017","unstructured":"Licona-Lim\u00f3n, P., Arias-Rojas, A. & Olgu\u00edn-Mart\u00ednez, E. IL-9 and Th9 in parasite immunity. Semin Immunopathol. 39, 29\u201338 (2017).","journal-title":"Semin Immunopathol."},{"key":"62495_CR63","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.immuni.2013.01.007","volume":"38","author":"W Yao","year":"2013","unstructured":"Yao, W. et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38, 360\u2013372 (2013).","journal-title":"Immunity"},{"key":"62495_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cei.12198","volume":"175","author":"L Ma","year":"2014","unstructured":"Ma, L. et al. Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin. Exp. Immunol. 175, 25\u201331 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"62495_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00281-016-0601-1","volume":"39","author":"S Koch","year":"2017","unstructured":"Koch, S., Sopel, N. & Finotto, S. Th9 and other IL-9-producing cells in allergic asthma. Semin Immunopathol. 39, 55\u201368 (2017).","journal-title":"Semin Immunopathol."},{"key":"62495_CR66","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.immuni.2013.07.020","volume":"39","author":"P Licona-Lim\u00f3n","year":"2013","unstructured":"Licona-Lim\u00f3n, P. et al. Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection. Immunity 39, 744\u2013757 (2013).","journal-title":"Immunity"},{"key":"62495_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09401-9","volume":"10","author":"G Xue","year":"2019","unstructured":"Xue, G., Jin, G., Fang, J. & Lu, Y. IL-4 together with IL-1\u03b2 induces antitumor Th9 cell differentiation in the absence of TGF-\u03b2 signaling. Nat. Commun. 10, 1376 (2019).","journal-title":"Nat. Commun."},{"key":"62495_CR68","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1182\/blood-2002-07-2348","volume":"101","author":"D Soler","year":"2003","unstructured":"Soler, D., Humphreys, T. L., Spinola, S. M. & Campbell, J. J. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 101, 1677\u20131682 (2003).","journal-title":"Blood"},{"key":"62495_CR69","doi-asserted-by":"crossref","unstructured":"Sie, C. et al. IL-24 intrinsically regulates Th17 cell pathogenicity in mice. J. Exp. Med. 219, e20212443 (2022).","DOI":"10.1084\/jem.20212443"},{"key":"62495_CR70","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.4049\/jimmunol.1800016","volume":"201","author":"B Li","year":"2018","unstructured":"Li, B., Jones, L. L. & Geiger, T. L. IL-6 Promotes T Cell Proliferation and Expansion under Inflammatory Conditions in Association with Low-Level ROR\u03b3t Expression. J. Immunol. 201, 2934\u20132946 (2018).","journal-title":"J. Immunol."},{"key":"62495_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1022136","volume":"13","author":"N Mabrouk","year":"2022","unstructured":"Mabrouk, N. et al. CXCR6 expressing T cells: Functions and role in the control of tumors. Front Immunol. 13, 1022136 (2022).","journal-title":"Front Immunol."},{"key":"62495_CR72","doi-asserted-by":"crossref","unstructured":"Huffman, A. P., Lin, J. H., Kim, S. I., Byrne, K. T. & Vonderheide, R. H. CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity. JCI Insight 5, e137263 (2020).","DOI":"10.1172\/jci.insight.137263"},{"key":"62495_CR73","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fcell.2019.00212","volume":"7","author":"Y Yan","year":"2019","unstructured":"Yan, Y. et al. CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention. Front Cell Dev. Biol. 7, 212 (2019).","journal-title":"Front Cell Dev. Biol."},{"key":"62495_CR74","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1091\/mbc.e09-12-1061","volume":"22","author":"B Herzog","year":"2011","unstructured":"Herzog, B., Pellet-Many, C., Britton, G., Hartzoulakis, B. & Zachary, I. C. VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Mol. Biol. Cell 22, 2766\u20132776 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"62495_CR75","doi-asserted-by":"publisher","first-page":"e0132496","DOI":"10.1371\/journal.pone.0132496","volume":"10","author":"G Malaponte","year":"2015","unstructured":"Malaponte, G. et al. Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis. PLoS One 10, e0132496 (2015).","journal-title":"PLoS One"},{"key":"62495_CR76","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1160\/TH15-03-0259","volume":"115","author":"P Ferroni","year":"2016","unstructured":"Ferroni, P. et al. VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients. Thromb. Haemost. 115, 143\u2013151 (2016).","journal-title":"Thromb. Haemost."},{"key":"62495_CR77","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/jamadermatol.2023.1461","volume":"159","author":"MC Schneeweiss","year":"2023","unstructured":"Schneeweiss, M. C., Merola, J. F., Wyss, R., Silverberg, J. I. & Mostaghimi, A. Venous Thromboembolism in Patients With Bullous Pemphigoid. JAMA Dermatol 159, 750\u2013756 (2023).","journal-title":"JAMA Dermatol"},{"key":"62495_CR78","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029740","volume":"12","author":"TL Chen","year":"2023","unstructured":"Chen, T. L., Huang, W. T., Loh, C. H., Huang, H. K. & Chi, C. C. Risk of Incident Venous Thromboembolism Among Patients With Bullous Pemphigoid or Pemphigus Vulgaris: A Nationwide Cohort Study With Meta-Analysis. J. Am. Heart Assoc. 12, e029740 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"62495_CR79","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1160\/TH15-04-0309","volume":"115","author":"M Cugno","year":"2016","unstructured":"Cugno, M. et al. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Thromb. Haemost. 115, 193\u2013199 (2016).","journal-title":"Thromb. Haemost."},{"key":"62495_CR80","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/exd.14209","volume":"29","author":"C Margaroli","year":"2020","unstructured":"Margaroli, C. et al. Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease. Exp. Dermatol 29, 1191\u20131198 (2020).","journal-title":"Exp. Dermatol"},{"key":"62495_CR81","first-page":"148","volume":"11","author":"F Ameglio","year":"1997","unstructured":"Ameglio, F. et al. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels. J. Biol. Regul. Homeost. Agents 11, 148\u2013153 (1997).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"62495_CR82","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/1523-1747.ep12606974","volume":"104","author":"LF Brown","year":"1995","unstructured":"Brown, L. F. et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J. Invest Dermatol 104, 744\u2013749 (1995).","journal-title":"J. Invest Dermatol"},{"key":"62495_CR83","doi-asserted-by":"crossref","unstructured":"Jordan, T. J. M. et al. The Eotaxin-1\/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid. J. Immunol. 211, 1216\u20131223 (2023).","DOI":"10.4049\/jimmunol.2300080"},{"key":"62495_CR84","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00428-009-0748-4","volume":"454","author":"A Dijkstra","year":"2009","unstructured":"Dijkstra, A. et al. Expression of ADAMs (\u201ca disintegrin and metalloprotease\u201d) in the human lung. Virchows Arch. 454, 441\u2013449 (2009).","journal-title":"Virchows Arch."},{"key":"62495_CR85","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1164\/rccm.200909-1396OC","volume":"181","author":"S Naus","year":"2010","unstructured":"Naus, S. et al. The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma. Am. J. Respir. Crit. Care Med 181, 1318\u20131328 (2010).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"62495_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/srep30451","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models. Sci. Rep. 6, 30451 (2016).","journal-title":"Sci. Rep."},{"key":"62495_CR87","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.rmed.2009.06.018","volume":"104","author":"O Matsuno","year":"2010","unstructured":"Matsuno, O. et al. Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry. Respir. Med 104, 34\u201339 (2010).","journal-title":"Respir. Med"},{"key":"62495_CR88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000066003","volume":"70","author":"Y Higuchi","year":"2002","unstructured":"Higuchi, Y., Yasui, A., Matsuura, K. & Yamamoto, S. CD156 transgenic mice. Different responses between inflammatory types. Pathobiology 70, 47\u201354 (2002).","journal-title":"Pathobiology"},{"key":"62495_CR89","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/archderm.1995.01690200106030","volume":"131","author":"E Schmidt","year":"1995","unstructured":"Schmidt, E. & Br\u00f6cker, E. B. Zillikens D. High levels of soluble CD23 in blister fluid of patients with bullous pemphigoid. Arch. Dermatol 131, 966\u2013967 (1995).","journal-title":"Arch. Dermatol"},{"key":"62495_CR90","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.4049\/jimmunol.150.8.3442","volume":"150","author":"R Alam","year":"1993","unstructured":"Alam, R. et al. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150, 3442\u20133448 (1993).","journal-title":"J. Immunol."},{"key":"62495_CR91","first-page":"27","volume":"12","author":"A Frezzolini","year":"2002","unstructured":"Frezzolini, A. et al. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Eur. J. Dermatol 12, 27\u201331 (2002).","journal-title":"Eur. J. Dermatol"},{"key":"62495_CR92","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000018085","volume":"198","author":"E Bornscheuer","year":"1999","unstructured":"Bornscheuer, E., Zillikens, D., Schr\u00f6der, J. M. & Sticherling, M. Lack of expression of interleukin 8 and RANTES in autoimmune bullous skin diseases. Dermatology 198, 118\u2013121 (1999).","journal-title":"Dermatology"},{"key":"62495_CR93","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2133.2006.07601.x","volume":"156","author":"H Nakashima","year":"2007","unstructured":"Nakashima, H. et al. Serum chemokine profile in patients with bullous pemphigoid. Br. J. Dermatol 156, 454\u2013459 (2007).","journal-title":"Br. J. Dermatol"},{"key":"62495_CR94","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/exd.14228","volume":"30","author":"PM Patel","year":"2021","unstructured":"Patel, P. M., Jones, V. A., Kridin, K. & Amber, K. T. The role of Dipeptidyl Peptidase-4 in cutaneous disease. Exp. Dermatol 30, 304\u2013318 (2021).","journal-title":"Exp. Dermatol"},{"key":"62495_CR95","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","volume":"96","author":"L Chakievska","year":"2019","unstructured":"Chakievska, L. et al. IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. J. Autoimmun. 96, 104\u2013112 (2019).","journal-title":"J. Autoimmun."},{"key":"62495_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17556-z","volume":"11","author":"LL Baggio","year":"2020","unstructured":"Baggio, L. L. et al. Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. Nat. Commun. 11, 3766 (2020).","journal-title":"Nat. Commun."},{"key":"62495_CR97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","volume":"85","author":"R Mentlein","year":"1999","unstructured":"Mentlein, R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul. Pept. 85, 9\u201324 (1999).","journal-title":"Regul. Pept."},{"key":"62495_CR98","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.4049\/jimmunol.162.8.4903","volume":"162","author":"S Struyf","year":"1999","unstructured":"Struyf, S. et al. CD26\/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J. Immunol. 162, 4903\u20134909 (1999).","journal-title":"J. Immunol."},{"key":"62495_CR99","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jdermsci.2024.01.003","volume":"113","author":"A N\u00e4tynki","year":"2024","unstructured":"N\u00e4tynki, A. et al. Proteomic changes related to actin cytoskeleton function in the skin of vildagliptin-treated mice. J. Dermatol Sci. 113, 121\u2013129 (2024).","journal-title":"J. Dermatol Sci."},{"key":"62495_CR100","doi-asserted-by":"crossref","unstructured":"Goletz, S. et al. Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin \u03b24 subunit. Br. J. Dermatol. 191, 140\u2013141 (2024).","DOI":"10.1093\/bjd\/ljae136"},{"key":"62495_CR101","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2023.11.014","volume":"90","author":"S Goletz","year":"2024","unstructured":"Goletz, S. et al. Laminin \u03b24 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid. J. Am. Acad. Dermatol 90, 790\u2013797 (2024).","journal-title":"J. Am. Acad. Dermatol"},{"key":"62495_CR102","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/25785826.2019.1619233","volume":"42","author":"W Nishie","year":"2019","unstructured":"Nishie, W. Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics. Immunol. Med 42, 22\u201328 (2019).","journal-title":"Immunol. Med"},{"key":"62495_CR103","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/jdv.17303","volume":"35","author":"S St\u00e4nder","year":"2021","unstructured":"St\u00e4nder, S. et al. The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid. J. Eur. Acad. Dermatol Venereol. 35, 1702\u20131711 (2021).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"62495_CR104","doi-asserted-by":"crossref","unstructured":"Guerrero-Juarez, C. F. et al. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita. Front. Immunol. 14, 1266359 (2023).","DOI":"10.3389\/fimmu.2023.1266359"},{"key":"62495_CR105","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/jdv.18220","volume":"36","author":"L Borradori","year":"2022","unstructured":"Borradori, L. et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J. Eur. Acad. Dermatol Venereol. 36, 1689\u20131704 (2022).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"62495_CR106","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","volume":"20","author":"MA Dickson","year":"2000","unstructured":"Dickson, M. A. et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell Biol. 20, 1436\u20131447 (2000).","journal-title":"Mol. Cell Biol."},{"key":"62495_CR107","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/bs.mie.2015.07.015","volume":"569","author":"C Arnette","year":"2016","unstructured":"Arnette, C., Koetsier, J. L., Hoover, P., Getsios, S. & Green, K. J. In Vitro Model of the Epidermis: Connecting Protein Function to 3D Structure. Methods Enzymol. 569, 287\u2013308 (2016).","journal-title":"Methods Enzymol."},{"key":"62495_CR108","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jim.2012.06.011","volume":"384","author":"SI Ochkur","year":"2012","unstructured":"Ochkur, S. I. et al. A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources. J. Immunol. Methods 384, 10\u201320 (2012).","journal-title":"J. Immunol. Methods"},{"key":"62495_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28020-5","volume":"13","author":"P Danaher","year":"2022","unstructured":"Danaher, P. et al. Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data. Nat. Commun. 13, 385 (2022).","journal-title":"Nat. Commun."},{"key":"62495_CR110","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-020-0922-4","volume":"3","author":"L Sol\u00e9-Boldo","year":"2020","unstructured":"Sol\u00e9-Boldo, L. et al. Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun. Biol. 3, 188 (2020).","journal-title":"Commun. Biol."},{"key":"62495_CR111","doi-asserted-by":"crossref","unstructured":"Sarkar, M. K. et al. Keratinocytes sense and eliminate CRISPR DNA through STING\/IFN-\u03ba activation and APOBEC3G induction. J. Clin. Invest. 133, e159393 (2023).","DOI":"10.1172\/JCI159393"},{"key":"62495_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/cpph.55","volume":"84","author":"A Kasprick","year":"2019","unstructured":"Kasprick, A., Bieber, K. & Ludwig, R. J. Drug Discovery for Pemphigoid Diseases. Curr. Protoc. Pharm. 84, e55 (2019).","journal-title":"Curr. Protoc. Pharm."},{"key":"62495_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 12, 323 (2011).","journal-title":"BMC Bioinforma."},{"key":"62495_CR114","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"62495_CR115","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res"},{"key":"62495_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"62495_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 14, 128 (2013).","journal-title":"BMC Bioinforma."},{"key":"62495_CR118","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"62495_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu, Z. Complex heatmap visualization. Imeta 1, e43 (2022).","journal-title":"Imeta"},{"key":"62495_CR120","first-page":"1892","volume":"32","author":"SM Zimmerman","year":"2022","unstructured":"Zimmerman, S. M. et al. Spatially resolved whole transcriptome profiling in human and mouse tissue using Digital Spatial Profiling. Genome Res 32, 1892\u20131905 (2022).","journal-title":"Genome Res"},{"key":"62495_CR121","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt, C. R. et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat. Biotechnol. 38, 586\u2013599 (2020).","journal-title":"Nat. Biotechnol."},{"key":"62495_CR122","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data. Cell Syst. 8, 281\u2013291.e289 (2019).","journal-title":"Cell Syst."},{"key":"62495_CR123","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nmeth.3734","volume":"13","author":"J Fan","year":"2016","unstructured":"Fan, J. et al. Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis. Nat. Methods 13, 241\u2013244 (2016).","journal-title":"Nat. Methods"},{"key":"62495_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"62495_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62495-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62495-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62495-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:34:11Z","timestamp":1757345651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62495-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62495"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62495-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.07.616103","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by Astra Zeneca. A.M., C.M. and C.N. are past or present employees of AstraZeneca and may hold stock and\/or stock options or interests in the company. E.S. has a scientific cooperation with Astra Zeneca and received consulting fees from Astra Zeneca (both not related to the present project). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7254"}}